Preventing HIV/AIDS among high-risk urban women: the cost-effectiveness of a behavioral group intervention.
OBJECTIVE
A human immunodeficiency virus (HIV) intervention trial for women at high risk for acquired immunodeficiency syndrome and attending an urban clinic was reported previously. The behavioral group intervention was shown to increase condom use behaviors significantly. This study retrospectively assessed the intervention's cost-effectiveness.


METHODS
Standard methods of cost and cost-utility analysis were used.


RESULTS
The intervention cost was just over $2000 for each quality-adjusted life-year saved; this is favorable compared with other life-saving programs. However, the results are sensitive to changes in some model assumptions.


CONCLUSIONS
Under most scenarios, the HIV prevention intervention was cost-effective.
Holtgrave
D R
DR
Department of Psychiatry and Behavioral Medicine, Medical College of Wisconsin, Milwaukee 53202, USA.
Kelly
J A
JA
D000163:Acquired Immunodeficiency Syndrome / Q000191:economics / Q000517:prevention & control*; D000328:Adult; D017280:Condoms / Q000706:statistics & numerical data; D003362:Cost-Benefit Analysis; D005260:Female; D006801:Humans; D010043:Outcome and Process Assessment, Health Care; D011314:Preventive Health Services / Q000191:economics*; D019057:Quality-Adjusted Life Years; D012189:Retrospective Studies; D012307:Risk Factors; D012725:Sexual Behavior; D014505:Urban Population